Effect of a conventional energy-restricted modified diet with or without meal replacement on weight loss and cardiometabolic risk profile in overweight women

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Metzner, Christine E ^a,b   Folberth Vögele, Anke ^a,c   Bitterlich, Norman ^d   Lemperle, Martin ^c   Schäfer, Sandy ^a,e   Alteheld, Birgit ^f   Stehle, Peter ^f   Siener, Roswitha ^f  

^a Bonn Education Association for Dietetics R A   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Ambulant Centre for Nutrition Education Frankfurt Am Main   (Germany)

^d Department of Biostatistics   (Germany)

^e B Vital   (Germany)

^f UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MEAL; OBESITY; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 80053174556     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-64     Document Type: Article

References (33)

1. Medical consequences of obesity. Bray GA, J Clin Endocrinol Metab 2004 89 2583 2589 10.1210/jc.2004-0535 15181027 (Pubitemid 38766335)
2. Abdominal obesity and the metabolic syndrome: contribution to global cardio-metabolic risk. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P, Arterioscler Thromb Vasc Biol 2008 28 1039 1049 10.1161/ATVBAHA.107.159228 18356555
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Third report of the National Cholesterol Education Program (NCEP), Circulation 2002 106 3143 3421 12485966
4. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Kahn HS, Valdez R, Am J Clin Nutr 2003 78 928 934 14594778 (Pubitemid 39663468)
5. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX, Diabetes Prevention Program Research Group, Am J Clin Nutr 2008 87 1212 1218 18469241 (Pubitemid 351679760)
6. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC, Couch W, Czerwinski SA, Chumlea WC, Siervogel RM, Towne B, Am J Clin Nutr 2008 88 1263 1271 18996861
7. Waist circumference and all-cause mortality in a large US cohort. Jacobs EJ, Newton CC, Wang Y, Patel AV, McCullough ML, Campbell PT, Thun MJ, Gapstur SM, Arch Intern Med 2010 170 1293 1301 10.1001/archinternmed.2010.201 20696950
8. Association of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CDA, Kostense PJ, Yudkin JS, Heine RJ, Nijpels G, Seidell JC, Am J Clin Nutr 2003 77 1192 1197 12716671 (Pubitemid 44858435)
9. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Park HS, Lee K, Diabet Med 2005 22 266 272 10.1111/j.1464-5491.2004.01395.x 15717873 (Pubitemid 40313852)
10. Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Lee JW, Lee HR, Shim JY, Im JA, Lee DC, Endocr J 2008 55 811 818 10.1507/endocrj.K08E-030 18493106
11. Do stress reactions cause abdominal obesity and comorbidities? Björntorp P, Obesity Rev 2001 2 73 86 10.1046/j.1467-789x.2001.00027.x (Pubitemid 33755917)
12. One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants. Ard JD, Coffman CJ, Lin PH, Svetkey LP, Am J Hypertens 2004 17 1156 1162 10.1016/j.amjhyper.2004.07.005 15607623 (Pubitemid 40029414)
13. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E, JAMA 2007 298 49 60 10.1001/jama.298.1.49 17609490 (Pubitemid 47026770)
14. Meal replacements in weight intervention. Ashley JM, St Jeor ST, Perumean-Chaney S, Schrage J, Bovee V, Obes Res 2001 9 Suppl 4 312S 320S 11707559
15. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Flechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G, Obes Res 2000 8 399 402 10.1038/oby.2000.48 10968732
16. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Heymsfield SB, van Mierlo CAJ, van der Knaap HCM, Heo M, Frier HI, Int J Obes 2003 27 537 549 10.1038/sj.ijo.0802258 (Pubitemid 36561010)
17. Bioelectrical impedance analysis - part II: utilization in clinical practice. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gámez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C, Clin Nutr 2004 23 1430 1453 10.1016/j.clnu.2004.09.012 15556267 (Pubitemid 39517638)
18. The hypertriglyceridemic waist phenotype among women. LaMonte MJ, Ainsworth BE, DuBose KD, Grandjean PW, Davis PG, Yanowitz FG, Durstine JL, Atherosclerosis 2003 171 123 130 10.1016/j.atherosclerosis.2003.07.008 14642414 (Pubitemid 37464637)
19. The Harris-Benedict studies of human basal metabolism: history and limitations. Frankenfield DC, Muth ER, Rowe WA, J Am Diet Assoc 1998 98 439 445 10.1016/S0002-8223(98)00100-X 9550168 (Pubitemid 28165024)
20. Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome. Noakes M, Foster PR, Keogh JB, Clifton PM, J Nutr 2004 134 1894 1899 15284372 (Pubitemid 39031313)
21. Effect of meal replacement on metabolic risk factors in overweight and obese subjects. König D, Deibert P, Frey I, Landmann U, Berg A, Ann Nutr Metab 2008 52 74 78 10.1159/000119416 18319587 (Pubitemid 351525942)
22. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, Clark NG, Diabetes Care 2004 27 2067 2073 10.2337/diacare.27.8.2067 15277443 (Pubitemid 38989258)
23. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. Lofgren I, Herron K, Zern T, West K, Patalay M, Shachter NS, Koo SI, Fernandez ML, J Nutr 2004 134 1071 1076 15113947 (Pubitemid 38619941)
24. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Tanká LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C, Circulation 2005 111 1883 1890 10.1161/01.CIR.0000161801. 65408.8D 15837940 (Pubitemid 40570207)
25. The predictive value of different measures of obesity for incident cardiovascular events and mortality. Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, Dörr M, Felix S, Lehnert H, Pittrow D, Silber S, Völzke H, Stalla GK, Wallaschofski H, Wittchen HU, J Clin Endocrinol Metab 2010 95 1777 1785 10.1210/jc.2009-1584 20130075
26. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Ashwell M, Hsieh SD, Int J Food Sci Nutr 2005 56 303 307 10.1080/09637480500195066 16236591 (Pubitemid 41631661)
27. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP, Circulation 2000 102 179 184 10889128 (Pubitemid 30451774)
28. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health, NIH Pub No 98-4083. Bethesda, MD: National Heart, Lung and Blood Institute 1998 228
29. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health, Obesity Res 1998 6 Suppl 2 51 209
30. Gamma glutamyl transferase. Whitfield JB, Crit Rev Clin Lab Sci 2001 38 263 355 10.1080/20014091084227 11563810 (Pubitemid 32826505)
31. Is serum gamma glutamyltransferase a marker of oxidative stress? Lee DH, Blomhoff R, Jacobs DR, Free Radic Res 2004 38 535 539 10.1080/ 10715760410001694026 15346644 (Pubitemid 38697087)
32. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A, Eur J Epidemiol 2009 24 369 373 10.1007/s10654-009-9346-7 19449164
33. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Stanger O, Weger M, Clin Chem Lab Med 2003 41 1444 1454 10.1515/CCLM.2003.222 14656024 (Pubitemid 37493559)